SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-016850
Filing Date
2022-04-29
Accepted
2022-04-29 17:10:18
Documents
13
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A acad-def14a_20220607.htm DEF 14A 3116788
2 GRAPHIC g53uafv0qknd000094.jpg GRAPHIC 13811
3 GRAPHIC g53uafv0qknd000003.jpg GRAPHIC 5236
4 GRAPHIC g53uafv0qknd000001.jpg GRAPHIC 26428
5 GRAPHIC g53uafv0qknd000096.jpg GRAPHIC 758189
6 GRAPHIC g53uafv0qknd000021.jpg GRAPHIC 327581
7 GRAPHIC g53uafv0qknd000030.jpg GRAPHIC 282433
8 GRAPHIC g53uafv0qknd000002.jpg GRAPHIC 29741
9 GRAPHIC g53uafv0qknd000063.jpg GRAPHIC 182874
10 GRAPHIC g53uafv0qknd000005.jpg GRAPHIC 34953
11 GRAPHIC g53uafv0qknd000006.jpg GRAPHIC 11677
12 GRAPHIC g53uafv0qknd000097.jpg GRAPHIC 742055
13 GRAPHIC g53uafv0qknd000004.jpg GRAPHIC 21563
  Complete submission text file 0001564590-22-016850.txt   6473987
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50768 | Film No.: 22877337
SIC: 2834 Pharmaceutical Preparations